Catalent Inc (NYSE:CTLT)
$ 55.25 -0.36 (-0.65%) Market Cap: 10.00 Bil Enterprise Value: 14.89 Bil PE Ratio: 0 PB Ratio: 2.77 GF Score: 81/100

Catalent Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 03:45PM GMT
Release Date Price: $101.48 (-2.42%)
Juan Esteban Avendano
BofA Securities, Research Division - Associate

Thank you. Hello. I am Juan Avendano. I am part of the Life Sciences Tools equity research team led by Derik De Bruin at Bank of America. I focus on biopharma services, namely CROs and CDMOs, and I'd like to thank everybody on the webcast for their participation. And please feel free to submit your questions through Veracast. It is a pleasure for me to conduct the following fireside chat with Catalent. We're joined by their current CFO, Wetteny Joseph; incoming CFO, Tom Castellano; as well as Paul Surdez from the Investor Relationships -- Investor Relations.

Gentlemen, thank you once again for your participation.

Wetteny Joseph;CFO

Thank you, Juan.

Juan Esteban Avendano;Wetteny Joseph;CFO
BofA Securities, Research Division - Associate

I guess to set the stage, would you like to do a few opening remarks on the company and also talk about the CFO transition that was announced yesterday?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot